Skip to main content
Equibles

Jefferies Financial Group Inc.

Position in JNJ — Johnson & Johnson

CIK 96223 NEW YORK, NY
Back to JNJ Full portfolio

Position in JNJ

as of Jun 30, 2026 · filed Aug 17, 2026
Position Value
$17,272,499
-$969,324 QoQ
Shares Held
68,010
-8.9% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.20%
of 13F equity value
Holder Rank
#806
of 4,663 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in JNJ Over Time

Shares Held

Position Value (USD)

Derivatives in JNJ

reported options exposure · as of Dec 31, 2025
CallValue
$620,850
CallShares
3,000
PutValue
$32,097,945
PutShares
155,100

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Jefferies Financial Group Inc. holds $358,862,750 across 12 Drug Manufacturers - General names. JNJ ranks #7 (4.8% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 AMGN
Amgen Inc
 239,779 $86,828,771
2 ABBV
AbbVie Inc.
 268,264 $67,505,952
3 MRK
Merck & Co., Inc.
 362,956 $46,639,846
4 GILD
Gilead Sciences, Inc.
 345,805 $43,689,003
5 AZN
Astrazeneca PLC
 186,676 $35,397,503
6 BMY
Bristol Myers Squibb Co
 508,740 $29,313,598
7 JNJ
Johnson & Johnson
This page 		68,010 $17,272,499
8 PFE
Pfizer Inc
 642,123 $15,462,321

All Filings in JNJ

Export CSV
39 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $17,272,499 68,010
2026-03-31 $18,241,823 74,627
2025-12-31 $32,097,945 155,100
2025-12-31 $22,604,113 109,225
2025-12-31 $620,850 3,000
2025-09-30 $18,249,036 98,420
2025-09-30 $11,143,742 60,100
2025-06-30 $13,793,477 90,301
2025-06-30 $1,909,375 12,500
2025-06-30 $6,507,150 42,600
2025-03-31 $7,026,972 42,372
2025-03-31 $547,272 3,300
2025-03-31 $4,991,784 30,100
2024-12-31 $90,122,266 623,166
2024-12-31 $73,770,662 510,100
2024-12-31 $1,880,060 13,000
2024-09-30 $5,104,890 31,500
2024-09-30 $4,878,006 30,100
2024-09-30 $24,542,852 151,443
2024-06-30 $24,152,940 165,250
2024-06-30 $4,399,416 30,100
2024-06-30 $4,604,040 31,500
2024-03-31 $31,746,834 200,688
2024-03-31 $2,056,470 13,000
2023-12-31 $1,598,748 10,200
2023-12-31 $6,471,794 41,290
2023-12-31 $971,788 6,200
2023-09-30 $2,834,650 18,200
2023-09-30 $6,541,500 42,000
2023-09-30 $6,939,752 44,557
2023-06-30 $16,883,040 102,000
2023-06-30 $20,061,024 121,200
2023-06-30 $5,704,315 34,463
2023-03-31 $6,510,000 42,000
2023-03-31 $18,726,325 120,815
2023-03-31 $1,720,500 11,100
2022-12-31 $20,314,750 115,000
2022-12-31 $13,169,787 74,553
2022-12-31 $75,500,210 427,400

Report a Problem

Category
Description
Email (optional, for follow-up)